InspireMD Inc
NASDAQ:NSPR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
InspireMD Inc
NASDAQ:NSPR
|
IL |
|
Antares Vision SpA
MIL:AV
|
IT |
|
S
|
Semtech Corp
F:SM2
|
US |
|
Sika AG
F:SIKA
|
CH |
|
C
|
China Life Insurance Co Ltd
F:CHL
|
CN |
|
Coherus BioSciences Inc
NASDAQ:CHRS
|
US |
|
X
|
X Fab Silicon Foundries EV
OTC:XFABF
|
BE |
|
D
|
Delta Israel Brands Ltd
TASE:DLTI
|
IL |
|
ALK-Abello A/S
OTC:AKBLF
|
DK |
|
Blue Hat Interactive Entertainment Technology
F:4Y80
|
CN |
|
Advantage Energy Ltd
TSX:AAV
|
CA |
|
Bimobject AB
F:BOJB
|
SE |
|
Vicat SA
PAR:VCT
|
FR |
|
Treasury Wine Estates Ltd
ASX:TWE
|
AU |
|
Foghorn Therapeutics Inc.
NASDAQ:FHTX
|
US |
|
Allsec Technologies Ltd
NSE:ALLSEC
|
IN |
|
C
|
Costco Wholesale Corp
DUS:CTO
|
US |
|
B
|
Beiersdorf AG
XHAM:BEI
|
DE |
|
B
|
Beiersdorf AG
DUS:BEI
|
DE |
Wall St Price Targets
NSPR Price Targets Summary
InspireMD Inc
According to Wall Street analysts, the average 1-year price target for
NSPR is 4.42 USD with a low forecast of 3.03 USD and a high forecast of 6.3 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NSPR's stock price target?
Price Target
4.42
USD
According to Wall Street analysts, the average 1-year price target for
NSPR is 4.42 USD with a low forecast of 3.03 USD and a high forecast of 6.3 USD.
What is the Revenue forecast for InspireMD Inc?
Projected CAGR
63%
Over the last 13 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 2 years is 63%.